Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Anti-VEGF aptamer is a potent inhibitor of tumor angiogenesis

April 14, 1999

News from AACR: orally active cemadotin analogue from BASF heads for clinic

April 14, 1999

AEterna presents evidence of clinical efficacy of lead MMP inhibitor at AACR meeting

April 14, 1999

4'-Thio-ara-C selected as potential clinical candidate at Southern Research Institute

April 14, 1999

Preclinical studies indicate potential of MMP inhibitor in brain and prostate cancers

April 14, 1999

Novel macrolide antitumor agent in early clinical trials at Wyeth-Ayerst

April 14, 1999

Spotlight on MMP inhibitors in development for cancer

April 14, 1999

Peptidomimetic inhibitors of cellular Ras protein processing developed at Merck

April 14, 1999

TX-1123: a lead PK-inhibitory antitumor agent without mitochondrial toxicity

April 13, 1999

Parke-Davis team achieves excellent preclinical results with new EGF receptor TK inhibitor

April 13, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...